Stanley R Frankel

Title: Innovations in Immunotherapy by Stanley R Frankel

Introduction

Stanley R Frankel is a notable inventor based in Summit, NJ (US). He has made significant contributions to the field of immunotherapy, particularly in the area of T cell modulation. His work focuses on developing methods and compositions that enhance the efficacy of T cell therapies.

Latest Patents

Stanley R Frankel holds 1 patent titled "Methods and combinations for treatment and T cell modulation." This patent relates to various methods, compositions, and uses involving immunotherapies, such as adoptive cell therapy and T cell therapy. The patent also discusses the use of immunomodulatory compounds, including structural or functional analogs of thalidomide and inhibitors of E3-ubiquitin ligase. The methods and compositions provided aim to improve the activity, efficacy, persistence, and proliferation of T cells for adoptive cell therapy.

Career Highlights

Frankel is associated with Juno Therapeutics GmbH, where he continues to advance research in immunotherapy. His innovative approaches have the potential to transform treatment methodologies for various diseases, particularly those that require T cell modulation.

Collaborations

Stanley R Frankel has collaborated with notable professionals in his field, including Jens Hasskarl and Michael Ports. These collaborations have further enriched his research and development efforts in immunotherapy.

Conclusion

Stanley R Frankel's contributions to immunotherapy through his innovative patent and collaborative efforts highlight his role as a key figure in advancing medical treatments. His work continues to pave the way for new therapeutic strategies in the field.